Although FHL2 silencing reduces cancer cell migration and invasion, there is no direct evidence that FHL2 contributes to cell migration and invasion as an adhesion component (Brun et al., 2013; Hua et al., 2016; Wang et al., 2020; Jiao et al., 2022). The gene discussed is FHL2; the disease is cancer.